CHCaleb Harris

Caleb Harris

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Caleb Harris has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:

  • Samapti Debnath

    Department of Surgical Oncology, North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences, Shillong, Meghalaya, India

    5 shared publications
  • Vikas Jagtap

    Department of Radiotherapy, Regional Institute of Medical Sciences (RIMS), Imphal, India

    5 shared publications
  • Baphiralyne Wankhar

    Department of Radiology, University of Virginia, Charlottesville, USA

    2 shared publications
  • Donboklang Lynser

    Department of Radiology, North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences (NEIGRIHMS), Shillong, India

    2 shared publications
  • Donboklang Lynser

    Department of Radiology, North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences (NEIGRIHMS), Shillong, Meghalaya, India

    2 shared publications
  • Evarisalin Marbaniang

    Pathology, North Eastern Indira Gandhi Regional Institute of Health & Medical Sciences (NEIGRIHMS), Shillong, IND

    2 shared publications

Latest Publications

  • Open Access

    GLOBOCAN 2024 and Cancer in India: Implications for Surgical Oncology

    by Pankaj Kumar Garg, Snita Sinukumar, Caleb Harris, S. P. Somashekhar


  • Open Access

    Determinants of Quality Breast Cancer Care in India: A Tri-Perspective Multicentric Exploration among Patients, Caregivers, and Health Care Providers

    by Surendran Veeraiah, Nisha K. Jose, Neha Tojan, Ruchi Tripathi, Sridevi Veluswami, Revathy Sudhakar, Divya Rajkumar, Arup Chakraborty, Biswajit Dubashi, Budhi Singh Yadav, et al.

    Background: Breast cancer is the most common female cancer worldwide. While innovative and effective cancer therapies hold promise for improving patient outcomes, several barriers hinder their development and utilization in India. The study aims to explore the perspectives of patients, caregivers, and healthcare providers (HCPs) on the quality of breast cancer care in India. Methods: The study was conducted under the ICMR-NHRP project; the data were collected using In-depth Interviews (IDIs) and Focus Group Discussion (FGDs), among patients with breast cancer caregivers, and HCPs, in equal representation, from 13 institutions across India, categorized under six zones. A total of 293 IDIs and 39 FGD transcripts were analysed using NVivo V15 software, which were later categorized using constructs from the Consolidated Framework for Implementation Research (CFIR).Findings: Overall, 21 categories emerged and were categorized under CFIR constructs. They revealed that breast cancer care in India is shaped by intersecting systemic, cultural, and personal factors. Quality care was reported to be enhanced by treatment advancement, HCP’s ' communication, financial schemes, and other patient-centric benefits. In contrast, challenges such as financial constraints, stigma, misconceptions, and facility-related barriers were also reported. Interpretation: Regional heterogeneity in India’s breast cancer landscape highlights the inadequacy of one-size-fits-all approaches and necessitates context-specific intervention packages that are equity-driven and culturally competent. Health system interventions for breast cancer care must be tailored to address distinct systemic, cultural, and personal factors.

  • Open Access

    Translation and Validation of the Khasi version of European Organisation for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C-30) and Oesophageal Cancer module (EORTC QLQ-OES-18)

    by Samapti Debnath, Caleb Harris, Shanthosh Priyan Sundaram

    Objectives: Oesophageal cancer (OC) is characterised by poor prognosis, a significant reduction in Quality of Life (QoL) and requirement for morbid therapy. The highest age-adjusted rate of OC incidence in India was seen in the East Khasi Hills district of Meghalaya, being 10 times the national average. This study aimed to develop and validate Khasi translations of the European Organisation for Research and Treatment of Cancer Core Quality of Life questionnaire (EORTC QLQ-C-30) Version 3.0 and EORTC QLQ-OES-18 questionnaires for use in the Khasi-speaking population of Meghalaya. Materials and Methods: This study was conducted as a part of a hospital-based cross-sectional study to develop and validate a Khasi-translated version of the QLQ-C-30 and QLQ-OES-18 questionnaires. The questionnaire was translated into the local (Khasi) language and validated (two-phase process: Two forward translations, two backward translations, followed by pilot testing). Reliability assessment was done using Cronbach’s alpha. The construct validity and the correlation of each scale of the QLQ-C30 and QLQ-OES18 were evaluated using Spearman’s correlation coefficient (r). Results: Cronbach’s alpha was satisfactory (>0.70) for all the scales of QLQ-C-30 and QLQ-OES-18. Convergent validity was moderate to high (r = 0.541 to 0.995) (Global health domain convergent validity r = 0.983–0.995), whereas discriminant validity was acceptably low (Global health domain divergent validity of r = 0.006–0.474) for all scales. Correlation coefficient values for each scale between QLQ-C-30 and QLQ-OES-18 ranged from 0.001 to 0.557. Conclusion: The Khasi versions of the QLQ-C-30 and QLQ-OES-18 demonstrate good psychometric validity, proving to be a reliable and culturally appropriate valuable tool for assessing QoL in OC patients in the Khasi-speaking population of North-East India.

  • Open Access

    Unveiling a Malignant Oncocytic Adrenocortical Carcinoma: A clinico-radiological challenge resolved by immunohistology and a brief review of literature

    by Ashim Roy, Pranjal Kalita, Evarisalin Marbaniang, Vandana Raphael, Caleb Harris, Sumit Kumar, Donboklang Lynser

    Oncocytic adrenocortical carcinoma (OACC) is a rare histopathological variant of adrenocortical carcinoma, a malignant tumor of adrenal cortical cells. The exact incidence of this unusual variant of ACC is unknown. It mainly occurs in the 5th decade of life with no gender predilection, without any established risk factor, and is characterised by the majority (>90%) of the tumor cells displaying oncocytic morphology. The patients mostly present with an abdominal mass with associated mass effects, or as an incidental finding detected during radiological evaluation for other reasons, and or occasionally with a functional status, usually hypercortisolism. It is an indolent variant with a lower stage, rare local invasion, delayed recurrence, and improved survivability, by virtue of which it differs from conventional adrenocortical carcinomas both clinically and prognostically. We present a case of non-functional left-sided oncocytic adrenocortical carcinoma in a 40-year-old female who was diagnosed radiologically as a high-grade malignancy, whereas histomorphology, along with immunohistochemistry, played a key role in diagnosis as OACC.

  • Setting Up an Oncology Multidisciplinary Team in Northeast India: Challenges and Initial Experience

    by Caleb Harris, Purnima Devi Laishram, Baphiralyne Wankhar, Ilaweibaphyrnai Myrthong, Umesh Das, Akash Handique, Donboklang Lynser, Yookarin Khonglah, Vikas Jagtap, Vandana Raphael


  • Open Access

    Dietary Risk Factors for Esophageal Cancer: A Systematic Review and Meta-Analysis of Case- Control Studies

    by Deepjyoti Saikia, Bhaskar Saikia, Caleb Harris

    Background Esophageal cancer (EC) is a major global health challenge with high mortality and poor prognosis. Dietary habits are significant and modifiable risk factors. Despite numerous case-control studies, a comprehensive quantitative synthesis of dietary factors and EC risk has been lacking. This study aimed to systematically review and meta-analyse evidence on these associations. Methods This systematic review and meta-analysis followed PRISMA guidelines and was registered (PROSPERO ID CRD420251026379). A comprehensive search of PubMed, Embase, and Cochrane Library identified English-language case-control studies (2005–2025) on EC and dietary factors. Data from 22 eligible studies were extracted, and bias assessed using Robins − 1. Statistical analyses used R Studio (p < 0.005). Results From 588 initial articles, 22 case-control studies were included. Meta-analysis showed hot food (OR 2.45), pickled food (OR 3.28), fried food (OR 2.40), and untreated water (OR 3.76) significantly increased EC risk. Conversely, vegetable (OR 0.57), fruit (OR 0.41), and fish (OR 0.29) consumption demonstrated protective effects. Meat, egg, and tea consumption showed no significant association. Conclusion This review identifies high-temperature food/beverage consumption, pickling, and frying as carcinogenic risk factors for EC. Conversely, raw fruits, vegetables, and fish intake are protective. These findings offer actionable public health directives, emphasizing dietary modifications and healthier food preparation to mitigate the esophageal cancer burden.

  • Compliance to Multimodality Treatment for Oesophageal Cancer at a High Incidence Region of India

    by Caleb Harris, Samapti Debnath, Vikas Jagtap, Donboklang Lynser, Vandana Raphael

    Oesophageal cancer (EC) is extremely aggressive in nature. Despite intensive multimodality treatment, survival is poor at the expense of high treatment–related morbidity. Meghalaya has the highest incidence of EC in India. Outcome of treatment for EC is dismal, and the compliance to the treatment is very low. This study strives to look for the compliance of patients to multimodality treatment at a tertiary hospital in Northeast India. This is an analysis of a prospectively maintained database (Ethics Committee approved) of all patients diagnosed with EC and advised management by the Multidisciplinary Team (MDT) at a tertiary health care centre at North East India between 31st January, 2023 and 31st December, 2024. The socio demographic, clinical, and treatment related details were recorded. The compliance to the treatment plan was assessed, with changes in the final treatment noted. Descriptive and analytical statistics were used. A total of 106 patients with EC were planned for curative (69.8%) and palliative (30.2%) treatment. The commonest ethnic background was Khasi-Jaintia tribe (88.6%%). Only 20.0% (12) of the patients who were advised neoadjuvant chemotherapy-surgery (NACT-Sx) or neoadjuvant chemoradiation-surgery (NACTRT-Sx) were able to complete the planned treatment. It was seen that 41(55.4%) patients receiving curative management were noncompliant. Patients belonging to urban region has higher odds of adherence to NACT-Sx [OR (95% CI): 1.400 (0.342–5.734)], NACTRT-Sx [OR (95% CI): 1.200 (0.304–4.743)], chemoradiation [OR (95% CI): 1.112 (0.983–1.842)], and palliative therapy [OR (95% CI): 1.015 (0.971–1.984)] than rural region. Compliance to multimodality treatment of EC at the study centre is poor. Further studies are recommended to find out the reason of low compliance to multimodality treatment.


  • Open Access

    Musculoskeletal tumors presenting to an oncology multidisciplinary team in Northeast India

    by Harris Caleb, Nadon Herman, Wankhar Baphiralyne, Lynser Donboklang, Lyngdoh Bifica, Toi Ruki, Borgohain Bhaskar, Agarwal Sharat, T G Khonglah, Jagtap Vikas, et al.

    Introduction: Musculoskeletal tumors (MSTs) are a challenge to diagnose and treat. Though they are generally rare, referral bias exists in tertiary institutions. This study was performed to audit the various MST presenting to an oncology Multidisciplinary Team (MDT) in Northeast India. Materials and Methods: An oncology MDT was set up in June 2016 at a tertiary hospital in Northeast India, which caters to a wide region comprising different ethnicities. In addition to patients diagnosed with MST, patients with suspected MST were also referred to the MDT. Data was collected prospectively and was analyzed up to March 2020. Our findings were also compared to those of other national and international studies. Results: During the study period, a total of 4704 cases (comprising 3426 patients) were discussed at the MDT meetings of which 174 (5%) were musculoskeletal [bone tumors {n = 110 (63.2%)}, soft tissue {n = 42 (24.2%)}] and skin lesions {n = 22 (12.6%)}]. The malignant among the bone tumors, soft tissue, and skin lesions were 59%, 88%, and 95%, respectively. After excluding secondary bone tumors and multiple myeloma, the total number of patients with primary bone tumor was found to be 88 (80%), out of which both malignant and benign were 50% each. The commonest site and diagnoses among malignant primary bone tumors were femur (15.9%) and osteosarcoma (25%), respectively. The commonest site and diagnosis among benign primary bone tumors were tibia (15.55%) and giant cell tumors (8%), respectively. The majority (56.9%) were male, with a median age of 39 years (range 3–90). The intent of treatment was curative in 71.9% of the malignant lesions. Conclusion: Osteosarcoma was found to be the most common malignancy among MSTs with male predominance. The accurate diagnosis of MST is aided by the MDT. Benign bone lesions may present to oncologists, and these differentials need to be considered.


  • Open Access

    Knowledge, Attitude and Practices of Areca Nut (kwai) Use among Employees of a Tertiary Health Care Institution in North-East India

    by Caleb Harris, Samapti Debnath, Fine One Laloo

    Objective: This study strives to look for the knowledge, attitudes, and practices of areca nut use among health care workers in a tertiary hospital in North-East India. Methods: A prospective, cross-sectional, questionnaire-based study was conducted among all health care and allied workers at a public sector teaching hospital in Meghalaya, Northeast India. A questionnaire, which was validated for content, was administered to the target population. Three domains of learned behavior towards areca nut viz. knowledge (cognitive), attitude (affective) and practice (psychomotor) were assessed. Data was analyzed using SPSS V21.0. Descriptive statistics were used. Result: A total of 434 participants completed the questionnaire. Majority of the respondents [52.8% (229)] had consumed Kwai (Areca nut) in the past 12 months. Kwai was perceived to have beneficial effects by 17.9% (78) of respondents. A total of 76.3% (331), 72.8% (316) and 62.2% (210) of respondents thought that Kwai consumption caused throat, oral and esophageal cancers respectively.48.0% (110) of the respondents swallowed the kwai juice in contrast to 32.4% (69) who spit the kwai juice. 61.6% (141) Kwai chewers tried quitting, out of which 41.8% (59) managed to stay away from Kwai for more than a year but eventually ended consuming Kwai again.62.4% (143) of the respondents claimed that the children in their family/neighbor consumed Kwai. Conclusion: Among our study population, the knowledge about harmful effects of areca nut is good. However, this knowledge has not translated into change in practices.


  • Quality of Life (QoL) Among Patients with Esophageal Cancer Using Validated European Organisation for Research and Treatment of Cancer (EORTC)—A Hospital-Based Cross-Sectional Study

    by Samapti Debnath, Caleb Harris, Shanthosh Priyan S, Vikas Jagtap

    Esophageal cancer has extremely aggressive nature and poor survival rate. An important Patient-Reported Outcome (PRO) indicator for assessing various clinical care pathways is quality of life (QoL). The objective of this study is to determine QoL among patients with esophageal cancer in a public sector hospital in North-East India. This prospective, cross-sectional study consisted of patients with esophageal cancer who sought oncology services between 14th July 2022 and 14th September 2022 at a tertiary public sector hospital. Validated European Organisation for Research and Treatment of Cancer [EORTC] QLQ-C30 Version 3.0 and EORTC QLQ-OES18 questionnaires were used to measure QoL. Among 57 patients, 98.2% patients had squamous cell carcinoma (SCC) where 64.9% had advanced disease. Mean scores were lower (compared to reference value) for global health (mean, 55.0; patients with unfavourable QoL [uQoL], 43.9%), physical function (mean, 68.7; uQoL, 52.6%), and role function (mean, 47.0; uQoL, 64.9%) and much higher symptom burden (fatigue, 57.9%; pain, 59.6%) was reported among our patients. Dysphagia was the major symptomatic burden (93.0%) in our patient. Patients with advanced stage disease had poor functional scores (physical functioning: stage II, 72.6; stage IVA, 64.5) and high symptom scores compared to early-stage disease. Significant association was found in regard to higher risk of dysphagia, reflux, and pain in advanced stage patients when compared to early-stage patients. The overall QoL in patients with esophageal cancer was poor. Patients with advanced cancer stage had poor QoL compared with early-stage cancer patients. Further studies in a homogenous group will guide future treatment.